Target Entity: KMHP Ventures Limited (KMHP)

Type of Deal: Acquisition via subscription to rights issue (wholly-owned subsidiary)

Stake/Capacity: 20,00,000 equity shares acquired. Post-acquisition, KMHP continues to remain as wholly-owned subsidiary.

Deal Value: ₹2,00,00,000.00 (Two Crore Rupees) at ₹10.00 per equity share

Funding Source: Cash consideration

Financial Impact:

  • KMHP reported turnover of Rs. NIL in Financial Year 2025-26
  • Total paid-up share capital was Rs. 10 Lakhs prior to this transaction
  • Investment is for working capital requirements of KMHP

Timeline: Transaction completed on June 22, 2026

Strategic Rationale:

  • KMHP plans to rollout retail stores under the brand name "Ugo Generic" operating in both Business to Business (B2B) and Business to Consumer (B2C) models
  • Will offer high quality generic medicines on a PAN India basis through owned stores
  • Plans to onboard approximately 12.5 lakh retail pharmacies under Ugo Generic network
  • Part of strategic investment in pharmaceutical segment expansion

Approval Status: No governmental or regulatory approvals required

Reference Regulation: SEBI Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated 13th July, 2023

Additional Background on Target Entity:

  • Incorporated on January 13, 2026
  • Domiciled in India
  • Engaged in pharmaceutical segment
  • Turnover history: FY 2025-26: Rs. NIL, FY 2024-25: N.A., FY 2023-24: N.A.

Transaction Details:

  • Does not fall within related party transactions
  • Promoter/promoter group/group companies have no interest in KMHP
  • Transaction conducted at arm's length basis